Insulin Lispro (Humalog (3 ml)) is a fast acting insulin analogue, prescribed for type 1 diabetes. The information provided on this page is intended to serve as a comprehensive resource and should not ...

Lilly announced that 3mL (300-unit) vials of Humalog (insulin lispro [recombinant]) and Humulin R U-100 (regular insulin [human, recombinant]) will be made available to hospitals in January 2010.

Patients may have trouble finding two different types of insulin products made by Eli Lilly. The company said it's experiencing a shortage of its 10 mL vials of Humalog and Insulin Lispro Injection ...

The U.S. Food and Drug Administration (FDA) has approved Humalog ® 200 units/mL KwikPen ® (insulin lispro 200 units/mL; U-200), a pre-filled pen containing a concentrated formulation of Lilly's ...

Eli Lilly, a major U.S.-based drugmaker, has issued a warning regarding a shortage of insulin medication in Canada, which is expected to persist through mid-April. The 10-millilitre vials of the ...

(Reuters) -Eli Lilly and Co on Wednesday said it will cut list prices by 70% for its most commonly prescribed insulin products, Humalog and Humulin, beginning from the fourth quarter of this year, a ...

Eli Lilly and Company has announced the launch of a lower-priced version of its lispro (Humalog) insulin in the United States. The new version is an "authorized generic" called Insulin Lispro. It will ...

Marks approval of first concentrated mealtime insulin analog in the U.S. and expands Lilly's portfolio of medicines for people with type 1 and type 2 diabetes INDIANAPOLIS, May 27, 2015 /PRNewswire/ - ...

Improved Health Outcomes Noted with Dulaglutide Therapy Lilly announced the availability of lower-priced, non-branded versions of Humalog® Mix75/25™ KwikPen® (insulin lispro protamine and insulin ...